Lokaltherapie von Metastasen beim oligometastasierten Mammakarzinom – die OLIGOMA-Studie
暂无分享,去创建一个
J. Dunst | D. Krug | D. Bauerschlag | R. Vonthein | A. Illen
[1] S. Siva,et al. SABR in oligometastatic breast cancer: Current status and future directions , 2021, Breast.
[2] M. Lux,et al. AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021 , 2021, Breast Care.
[3] I. König,et al. Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients with Oligometastatic Breast Cancer: Study protocol for a randomized controlled multi-national and multi-center clinical trial (OLIGOMA) , 2021, Clinical and translational radiation oncology.
[4] M. Lux,et al. Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer , 2018, Geburtshilfe und Frauenheilkunde.
[5] M. Lux,et al. Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer , 2018, Geburtshilfe und Frauenheilkunde.